Due to its toxicity profile, there are currently no injectable formulations of this drug on the US market.

Especially are desired improvements in antitumor activity, toxicity profile, drug formulation and pharmacology.

Thus the difference in the C-terminal sequence might affect the anticonvulsant and behavioral toxicity profile.

This facet of their toxicity profile exceeds commonly held safety standards for pharmaceuticals.

Citicoline has a very low toxicity profile in animals and humans.

For these regimens, a better toxicity profile is generally expected.

With an excellent toxicity profile, extremely low cost, vast availability, and no need for disposal worry, anybody can build a water-based cooling system.

The toxicity profile is based on what was found in the phase III trial.

The absence of any observed adverse events in several animal species suggests that the product has a very low toxicity profile.

The toxicity profile and response rates in children are similar to that observed in adults.